Estimation of Cost per Effectively Treated Patients with Biologic Disease Modifying Anti-Rheumatic Drugs in US Veterans with Rheumatoid Arthritis

被引：0
|
作者：
Cannon, Grant W. [1 ,2 ]
Teng, Chia-Chen [1 ,2 ]
He, Tao [1 ,2 ]
Leng, Jianwei [3 ,4 ]
Lu, Chao-Chin [1 ,2 ]
Tang, Derek [5 ]
Shah, Neel [5 ]
Harrison, David J. [5 ]
Sauer, Brian [1 ,2 ]
机构：
[1] Salt Lake City VA, Salt Lake City, UT USA
[2] Univ Utah, Salt Lake City, UT USA
[3] Salt Lake City VA, Salt Lake Citty, UT USA
[4] Univ Utah, Salt Lake Citty, UT USA
[5] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
494
引用
收藏
页码：S213 / S213
页数：1
相关论文
共 50 条
  • [1] SECONDARY SARCOPENIA IN RHEUMATOID ARTHRITIS PATIENTS TREATED BY BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Hasegawa, Eriko
    Ito, Satoshi
    Kurosawa, Yoichi
    Kobayashi, Daisuke
    Abe, Asami
    Otani, Hiroshi
    Nakazono, Kiyoshi
    Murasawa, Akira
    Narita, Ichiei
    Ishikawa, Hajime
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1622 - 1622
  • [2] SARCOPENIA IN PATIENTS WITH RHEUMATOID ARTHRITIS ON THE TREATMENT WITH BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Hasegawa, E.
    Ito, S.
    Kurosawa, Y.
    Taniguchi, S.
    Kobayashi, D.
    Abe, A.
    Otani, H.
    Nakazono, K.
    Murasawa, A.
    Narita, I.
    Ishikawa, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 985 - 985
  • [3] ADHERENCE TO BIOLOGIC AND CONVENTIONAL DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Mishra, P.
    VALUE IN HEALTH, 2018, 21 : S198 - S198
  • [4] COMPARATIVE EFFECTIVENESS OF BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUG THERAPY IN US VETERANS WITH RHEUMATOID ARTHRITIS
    Cannon, G. W.
    He, T.
    Teng, C. -C.
    Leng, J.
    Lu, C. -C.
    Tang, D.
    Shah, N.
    Harrison, D. J.
    Sauer, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 446 - 447
  • [5] Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis
    Choy, Ernest
    Aletaha, Daniel
    Behrens, Frank
    Finckh, Axel
    Gomez-Reino, Juan
    Gottenberg, Jacques-Eric
    Schuch, Florian
    Rubbert-Roth, Andrea
    RHEUMATOLOGY, 2017, 56 (05) : 689 - 697
  • [6] USE OF BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RELATION TO THE RISK OF LYMPHOMA: A COHORT STUDY OF US VETERANS WITH RHEUMATOID ARTHRITIS
    Singh, N.
    Peterson, A.
    Baraff, A.
    Korpak, A.
    Vaughan-Sarrazin, M.
    Smith, N.
    Curtis, J.
    Weiss, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 369 - 369
  • [7] Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
    Xerxes Pundole
    Natalia V. Zamora
    Harish Siddhanamatha
    Heather Lin
    Jean Tayar
    Leung Cheuk Hong
    Liang Li
    Maria E. Suarez-Almazor
    Clinical Rheumatology, 2020, 39 : 787 - 794
  • [8] Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
    Pundole, Xerxes
    Zamora, Natalia V.
    Siddhanamatha, Harish
    Lin, Heather
    Tayar, Jean
    Hong, Leung Cheuk
    Li, Liang
    Suarez-Almazor, Maria E.
    CLINICAL RHEUMATOLOGY, 2020, 39 (03) : 787 - 794
  • [9] Use of disease modifying anti-rheumatic drugs and risk of multiple myeloma in US Veterans with rheumatoid arthritis
    Tokareva, Kate
    Peterson, Alexander C.
    Baraff, Aaron
    Chung, Sarah P.
    Barton, Jennifer
    Baker, Joshua F.
    England, Bryant R.
    Mikuls, Ted R.
    Smith, Nicholas L.
    Coffey, David G.
    Weiss, Noel S.
    Singh, Namrata
    BMC RHEUMATOLOGY, 2025, 9 (01)
  • [10] Use of Disease Modifying Anti-rheumatic Drugs and Risk of Multiple Myeloma in US Veterans with Rheumatoid Arthritis
    Singh, Namrata
    Peterson, Alexander
    Baraff, Aaron
    Chung, Sarah
    Coffey, David
    England, Bryant
    Reid, Pankti
    Baker, Joshua
    Barton, Jennifer
    Smith, Nicholas
    Mikuls, Ted
    Weiss, Noel
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1834 - 1835
12345